ECPLA, a lysergamide lysergic acid diethylamidean (LSD) analog, is a potent 5-HT2A agonist (EC50 of 14.6 nM) for Gq-mediated calcium flux. ECPLA has high affinity for most serotonin receptors, alpha2-adrenoceptors, and D2-like dopamine receptors[1].
Molecular Weight:
335.44
CAS Number:
[2349367-50-4]
Formula:
C21H25N3O
Target:
5-HT Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
